• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情期间的抗菌药物管理与药品处方集限制:哪些药物受限,由谁来决定?

Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?

作者信息

Mena Lora Alfredo J, Burgos Rodrigo, Borgetti Scott, Chaisson Lelia H, Bleasdale Susan C

机构信息

University of Illinois at Chicago, Chicago, IL, USA.

出版信息

Antimicrob Steward Healthc Epidemiol. 2023 Jun 30;3(1):e116. doi: 10.1017/ash.2023.205. eCollection 2023.

DOI:10.1017/ash.2023.205
PMID:37502239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10369429/
Abstract

COVID-19 therapies were challenging to deploy due to evolving literature and conflicting guidelines. Antimicrobial stewardship can help optimize drug use. We conducted a survey to understand the role of stewardship and formulary restrictions during the pandemic. Restrictions for COVID-19 therapies were common and approval by infectious disease physicians often required.

摘要

由于文献不断更新且指南相互冲突,新冠病毒病(COVID-19)治疗方法的应用具有挑战性。抗菌药物管理有助于优化药物使用。我们开展了一项调查,以了解大流行期间管理和处方限制的作用。对COVID-19治疗方法的限制很常见,且往往需要传染病科医生批准。

相似文献

1
Antimicrobial stewardship and drug formulary restrictions during COVID-19: what is restricted and who decides?新冠疫情期间的抗菌药物管理与药品处方集限制:哪些药物受限,由谁来决定?
Antimicrob Steward Healthc Epidemiol. 2023 Jun 30;3(1):e116. doi: 10.1017/ash.2023.205. eCollection 2023.
2
Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey.美国2019冠状病毒病(COVID-19)大流行期间瑞德西韦的使用及抗菌药物管理限制:一项横断面调查
Antimicrob Steward Healthc Epidemiol. 2023 Mar 31;3(1):e63. doi: 10.1017/ash.2023.146. eCollection 2023.
3
Impact of a remdesivir formulary restriction by antimicrobial stewardship on drug utilization and cost at a safety-net community hospital during the COVID-19 pandemic.在COVID-19大流行期间,抗菌药物管理部门对瑞德西韦处方集的限制对一家安全网社区医院的药物使用和成本的影响。
Antimicrob Steward Healthc Epidemiol. 2024 Oct 7;4(1):e164. doi: 10.1017/ash.2024.438. eCollection 2023.
4
Evaluation of Antimicrobial Stewardship Programs (ASPs) and their perceived level of success at Makkah region hospitals, Kingdom of Saudi Arabia.沙特阿拉伯王国麦加地区医院抗菌药物管理计划(ASPs)及其成功感知水平的评估。
Saudi Pharm J. 2020 Oct;28(10):1166-1171. doi: 10.1016/j.jsps.2020.08.005. Epub 2020 Aug 14.
5
Hospital-based antimicrobial stewardship, India.医院为基础的抗菌药物管理,印度。
Bull World Health Organ. 2023 Jan 1;101(1):20-27A. doi: 10.2471/BLT.22.288797. Epub 2022 Nov 9.
6
Successful Implementation of an Antimicrobial Stewardship Program at an Academic Medical Center.在一家学术医疗中心成功实施抗菌药物管理计划。
Hosp Pharm. 2017 Jul;52(7):508-513. doi: 10.1177/0018578717721535. Epub 2017 Jul 26.
7
Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs.抗菌药物管理是新冠疫情应对工作的核心:对维持和建立相关项目的启示
Curr Infect Dis Rep. 2020;22(9):23. doi: 10.1007/s11908-020-00734-x. Epub 2020 Jul 3.
8
Characteristics of Antimicrobial Stewardship Programs at Veterans Affairs Hospitals: Results of a Nationwide Survey.退伍军人事务医院抗菌药物管理计划的特点:一项全国性调查的结果
Infect Control Hosp Epidemiol. 2016 Jun;37(6):647-54. doi: 10.1017/ice.2016.26. Epub 2016 Feb 24.
9
Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities.新冠疫情期间纽约市一家医院的抗菌药物管理视角:挑战与机遇。
Am J Health Syst Pharm. 2021 Mar 31;78(8):743-750. doi: 10.1093/ajhp/zxaa419.
10
Antimicrobial Stewardship (AMS) During COVID-19: Eyes and Ears on the AMS Team.COVID-19 期间的抗菌药物管理(AMS):AMS 团队的眼睛和耳朵。
Stud Health Technol Inform. 2023 Jun 22;304:62-66. doi: 10.3233/SHTI230370.

引用本文的文献

1
Impact of a remdesivir formulary restriction by antimicrobial stewardship on drug utilization and cost at a safety-net community hospital during the COVID-19 pandemic.在COVID-19大流行期间,抗菌药物管理部门对瑞德西韦处方集的限制对一家安全网社区医院的药物使用和成本的影响。
Antimicrob Steward Healthc Epidemiol. 2024 Oct 7;4(1):e164. doi: 10.1017/ash.2024.438. eCollection 2023.
2
Levees for a hundred-year flood: impact of a syndrome-based antimicrobial stewardship intervention for coronavirus disease 2019 on antimicrobial use and resistance.应对百年一遇洪水的防洪堤:基于综合征的抗菌药物管理干预措施对2019冠状病毒病抗菌药物使用和耐药性的影响。
Antimicrob Steward Healthc Epidemiol. 2024 Sep 18;4(1):e131. doi: 10.1017/ash.2024.383. eCollection 2024.

本文引用的文献

1
Remdesivir use and antimicrobial stewardship restrictions during the coronavirus disease 2019 (COVID-19) pandemic in the United States: A cross-sectional survey.美国2019冠状病毒病(COVID-19)大流行期间瑞德西韦的使用及抗菌药物管理限制:一项横断面调查
Antimicrob Steward Healthc Epidemiol. 2023 Mar 31;3(1):e63. doi: 10.1017/ash.2023.146. eCollection 2023.
2
Dispensing of Ivermectin From Veterans Administration Pharmacies During the COVID-19 Pandemic.新冠疫情期间退伍军人事务部药房的伊维菌素配药情况。
JAMA Netw Open. 2023 Feb 1;6(2):e2254859. doi: 10.1001/jamanetworkopen.2022.54859.
3
SHEA statement on antibiotic stewardship in hospitals during public health emergencies.
医疗保健流行病学学会关于公共卫生紧急情况期间医院抗生素管理的声明。
Infect Control Hosp Epidemiol. 2022 Nov;43(11):1541-1552. doi: 10.1017/ice.2022.194. Epub 2022 Sep 14.
4
Minimum Manufacturing Costs, National Prices, and Estimated Global Availability of New Repurposed Therapies for Coronavirus Disease 2019.2019年冠状病毒病新型重新利用疗法的最低制造成本、国家价格及全球可及性估计
Open Forum Infect Dis. 2021 Dec 17;9(1):ofab581. doi: 10.1093/ofid/ofab581. eCollection 2022 Jan.
5
COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications.COVID-19 与抗菌药物管理:经验教训、最佳实践和未来影响。
Int J Infect Dis. 2021 Dec;113:103-108. doi: 10.1016/j.ijid.2021.10.001. Epub 2021 Oct 5.
6
COVID-19 Use Causes Tocilizumab Shortage.COVID-19 治疗导致托珠单抗短缺。
Cancer Discov. 2021 Dec 1;11(12):2950. doi: 10.1158/2159-8290.CD-NB2021-0386.